JSM2023
Back to all people

Shahrul Mt-Isa

Merck Sharp & Dohme
2 appearances in the program

Sessions & presentations

Contributed Poster Presentations: Biopharmaceutical Section
Presentation: 09 Benefit-Risk Assessment with Recurrent Events of Multiple Types
Contributed Posters · Mon, Aug 7 , 10:30 AM
Co-Author
Biopharmaceutical Section P.M. Roundtable Discussion (Added Fee)
Presentation: ML06: Are We Ready to Tackle the Health Technology Assessment (HTA) Hurdle Beyond Regulatory Approval?
Roundtables – Lunch · Mon, Aug 7 , 12:30 PM
Discussion Leader
↑